HIV-Negative Partnered Men's Willingness to Use Pre-Exposure Prophylaxis and Associated Factors Among an Internet Sample of U.S. HIV-Negative and HIV-Discordant Male Couples by Mitchell, Jason W. & Stephenson, Rob
ORIGINAL ARTICLES
HIV-Negative Partnered Men’s Willingness
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and HIV-Discordant Male Couples
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Abstract
Purpose: Research on male couples’ willingness to use pre-exposure prophylaxis (PrEP) is critically lacking.
Methods: A cross-sectional 2011 Internet survey collected dyadic data from 275 HIV-negative and 58 HIV-
discordant male couples to describe 631 HIV-negative partnered mens’ willingness to use PrEP and associated
couple-level demographic and behavioral factors with multivariate multilevel modeling.
Results: Fifty-three percent were very to extremely likely to use PrEP. Willingness was positively associated
with being in a mixed race and behaviorally non-monogamous relationship, and with amyl nitrate use with
sex outside the relationship. Willingness was negatively associated with having a college education.
Conclusion: Prevention efforts should educate male couples about the potential benefits of PrEP.
Keywords:HIV prevention, male couples, pre-exposure prophylaxis (PrEP), relationship characteristics, willing-
ness to use.
Introduction
Men who have sex with men (MSM) are the onlygroup within the U.S. HIV epidemic which continues
to have increased HIV incidence.1 Although HIV risk among
MSM was long messaged as driven by multiple casual sex
partners, recent evidence shows that between one- and
two-thirds of MSM acquire HIV from their main partner
(i.e., male couples).2,3 Within the context of HIV-negative
and discordant male couples’ relationships, increases in
HIV risk are attributed to lack of confirmation of both part-
ners’ HIV-status (as negative) before condomless anal sex
(CAS), higher number of anal sex acts without condoms,
more frequent receptive roles, and lack of viral load suppres-
sion for the HIV-positive partner.2–8 HIV testing rates within
these relationships are also low despite CAS occurring
within and outside the relationships.9–12 Partnered MSM
also test less frequently because they perceive to be at less
risk due to being in a relationship,13 and viewing their
main partner as dependable for being trustworthy.10
Pre-exposure prophylaxis (PrEP)—a daily regimen of
ART (i.e., Truvada) taken by those who are HIV-negative
to prevent the acquisition of HIV—is one promising biomed-
ical approach to reducing the risk of HIV infection among
male couples. Efficacy trials have demonstrated that use of
PrEP can reduce the risk of sexual acquisition of HIV infec-
tion.14–18 In the multinational iPrEPx study, the safety and
efficacy of PrEP in HIV uninfected MSM was established
and showed a 44% reduction in incidence of HIV infection.14
Participants in this randomized control trial study who
reported using PrEP on 90% or more of the days had a
72.8% reduction in acquisition risk for HIV.14 Since these
findings, the U.S. Food and Drug Administration on July
16, 2012, approved Truvada for PrEP in combination
with safer sex practices to reduce the risk of sexually ac-
quired HIV-infection in adults at high risk, and at the fore-
front of the targeting of PrEP are high-risk MSM.19 The
CDC has also provided guidelines for who may best benefit
from PrEP.20 With respect to gay men and other MSM, this
includes anyone who: is in an ongoing relationship with an
HIV-positive partner (i.e., HIV-discordant male couples);
is not in a mutually exclusive monogamous relationship
with a partner who recently tested HIV-negative (i.e., HIV-
negative male couples with an open relationship or perceived
to be monogamous but not); and has had CAS or been diag-
nosed with a sexually transmitted disease (STD) in the past 6
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months.4 However, behavioral research into the factors shap-
ing PrEP willingness, acceptability, and use among male
couples is at a nascent stage.
Recent studies have examined attitudes, awareness and
willingness to use PrEP among MSM primarily in the
U.S.,21–31 with more limited research in Australia, China,
France, Thailand, UK, and Canada32–39 through an individual
lens, focusing on the individual characteristics of men that
shape their desire and ability to use and adhere to PrEP. In
general, this body of research has illustrated that MSM, and
in particular high-risk MSM (those with multiple sex part-
ners), have positive attitudes towards the adoption of PrEP
as a HIV prevention strategy. However, this focus on high-
risk MSM has almost ignored male couples’ willingness to
use PrEP. Studies that provide this type of data are critical
to increase PrEP uptake given that two of the Centers for Dis-
ease Control and Prevention’s (CDC) three recommended
PrEP guidelines include those who are in a relationship. By
using dyadic data collected in 2011 from a nation-wide U.S.
Internet study with 333 gay male couples comprised of 275
HIV-negative and 58 HIV-discordant dyads, we sought to de-
scribe 631 HIV-negative partnered mens’ willingness to use
PrEP, and to assess couple-level demographic and behavioral
factors associated with their willingness to use PrEP.
Methods
The Medical College of Wisconsin Institutional Review
Board approved the study protocol; methods have been previ-
ously described.9,10 Recruitment for this study sample was
conducted through Facebook banner advertising: In 2011, ad-
vertisements targeting partnered men who reported in their
Facebook profile being ‡ 18 years of age, living in the U.S.,
interested in men, and being in a relationship, engaged, or
married. Banner advertisements briefly described the purpose
of the study and included a picture of a male couple. Of a total
of 7,994 Facebook users who clicked on an advertisement,
4,056 (51%) answered eligibility questions: 722 (18%), repre-
senting both men of 361 MSM couples provided consent
and completed the study questionnaire. A total of 631 HIV-
negative MSM, representing 275 concordantly negative and
58 HIV-discordant male couples (n= 333 dyads), are included
in this analysis. Men were eligible to participate if they were
‡ 18 years of age, lived in the U.S., were in a sexual relation-
ship with another male, and had had oral and/or anal sex with
this partner within the previous three months. A partner refer-
ral system was embedded in the online survey to enable data
collection from both men in the couple. Post-hoc analyses of
response consistency in several variables and email addresses
were used to verify couples’ relationships.
Measures
Participants’ willingness to use PrEP was assessed by 1-
item with a 5-point Likert-type scale that had response op-
tions ranging from 0 (Not at all), 1 (Not very likely), 2
(Somewhat likely), 3 (Very likely) to 4 (Extremely likely).
Participants were asked: ‘‘How likely are you to take an
HIV medication (i.e., Truvada) daily if the medication
helped lower their chances of contracting HIV and consistent
condom use is difficult for you?’’
Several demographic (e.g., age, race) and relationship char-
acteristics (e.g., relationship length) were assessed, as well as
self and primary partner’s HIV status, engagement in CAS
within the relationship, whether sex had occurred with any ca-
sual MSM partners within the previous three months, includ-
ing CAS with that casual MSM partner. Substance use with
sex was assessed categorically by partner type. Other charac-
teristics about this sample have been reported.40–50
Dyadic data from 333 dyads with 631 HIV-negative
partnered men were analyzed using Stata v12 (StataCorp, Col-
lege Station, TX) following recommended guidelines.51,52
Table 1. Characteristics of the Sample: 275
HIV-Negative Concordant Male Couples
and 58 HIV-Discordant Male Couples
Couple-level demographic
characteristic
% (n = 333
dyads)
Relationship HIV status
In HIV-discordant relationship 17% (58)
In concordantly HIV-negative
relationship
83% (275)
Mixed or nonwhite race 34% (113)
Education level: Both men had
at least a bachelor’s degree
34% (112)
Employment status: Both men employed 66% (220)
Had primary care provider:
One or both men reported yes
61% (203)
Geographical location: Urban/suburban 88% (279)
Mean (SD)
Individual age [range: 18–68 years] 32.2 (10.6)
Age difference between partners 4.9 (5.7)
Relationship length [range: 0.25–35 years] 4.8 (5.4)
Cohabitation length
[range: 0.08–31.7 years]a
5.0 (5.7)
Couple-level sexual behavior % (n)
CAS practiced within relationship 83% (278)
Sex outside of relationship 30% (101)
CAS outside of relationshipb 63% (64)
CAS within and out of relationshipb 53% (54)
Couple-level substance use with
sex—main partner
% (n)
Party drugsc 11% (35)
EDMd 18% (61)
Amyl nitrate (e.g., poppers) 14% (46)
Marijuana 30% (101)
Alcohol 83% (278)
Couple-level substance use with
sex—casual partner
% (n)
Party drugsc 3% (11)
EDMd 9% (30)
Amyl nitrate (e.g., poppers) 10% (32)
Marijuana 8% (28)
Alcohol 17% (58)
With the exception of condomless anal sex (CAS) practiced
within the relationship, all reported behaviors include male couples
in which one or both men in the relationship self-reported engaging
in that behavior (e.g., amyl nitrate with sex—main partner).
aRegional data represents the individual men because not all cou-
ples reported living together.
bData represents participants who reported living with their main
partner for at least one month or longer.
cData reflects among the couples who had one or both partners
that had sex outside of their relationship.
dParty drugs include ecstasy, ketamine, gamma hydroxybutyrate
(GHB), cocaine, and methamphetamine.
eEDM, erectile dysfunction medication.
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Descriptive statistics were calculated. Responses from both
partners were used to create couple-level dummy variables
to describe and assess demographic and behavioral factors at
the couple-level. Independent couple-level variables that were
significantly (P< .05) associated with the outcome in the bivar-
iate random-effects regression models were included in a mul-
tivariate random-effects multilevel regression model with
maximum likelihood estimation. For the final model, backward
elimination was used to remove independent variables that
remained non-significant until all variables, excluding the
pre-determined confounders, remained significant. Age differ-
ence between partners, HIV-status, and relationship length
were included as potential confounders for the model. The co-
efficients, standard errors, and statistical significance for the
factors in the bivariate and multivariate models are reported.
Results
The average age of men and age difference between part-
ners was 32.2 and 4.9 years, respectively (Table 1). Mean re-
lationship length was approximately 5 years. About one third
of couples were nonwhite or mixed race; another third had
both partners who earned at least a bachelor’s degree. Most
partners in the couple reported being employed, having a
Table 2. Factors Significantly Associated with Attitude Toward Using PrEP Among 631 HIV-Negative
Partnered MSM in 275 HIV-Negative and 58 HIV-Discordant Male Couples: Results from Bivariate
and Final Multivariate Random-Effects Multilevel Regression Models
Bivariate
Models
Final multivariate
model
Individual-level demographic b (SE) b (SE)
Age 0.01 (0.01)
Education: bachelor’s degree or higher 0.33 (0.11)** 0.32 (0.11)**
Hispanic (vs. non-Hispanic) 0.36 (0.19)*
Has health insurance 0.33 (0.13)**
Has primary care provider 0.20 (0.12)
Couple-level demographic b (SE) b (SE)
Relationship length
5 years and less (ref) 0.23 (0.13)* 0.23 (0.12)
Greater than 5 years
Age difference between partners 0.01 (0.01) 0.01 (0.01)
HIV status of relationship
Negative concordant (ref) 0.27 (0.17) 0.20 (0.16)
Discordant
Race
Mixed or nonwhite (ref) 0.36 (0.12)** 0.31 (0.12)**
White
Couple-level sexual behavior b (SE) b (SE)
CAS practiced within relationship 0.24 (0.16)
Sex outside of relationship
One or both men reported ‘‘Yes’’ (ref) 0.36 (0.12)** 0.32 (0.14)*
Both partners reported ‘‘No’’
CAS with casual MSM partner
One or both men reported ‘‘Yes’’ (ref) 0.28 (0.22)
Both partners reported ‘‘No’’
CAS with both partner types
One or both men reported ‘‘Yes’’ (ref) 0.33 (0.15)*
Both partners reported ‘‘No’’
Amyl nitrate use with sex within relationship
One or both men reported ‘‘Yes’’ (ref) 0.20 (0.17)
Both partners reported ‘‘No’’
Amyl nitrate use with sex outside relationship
One or both men reported ‘‘Yes’’ (ref) 0.62 (0.19)** 0.47 (0.21)*
Both partners reported ‘‘No’’
EDM use with sex within relationship
One or both men reported ‘‘Yes’’ (ref) 0.08 (0.15)
Both partners reported ‘‘No’’
EDM use with sex outside relationship
One or both men reported ‘‘Yes’’ (ref) 0.42 (0.20)*
Both partners reported ‘‘No’’
Results from final multivariate random-effects multilevel regression model controlled for couples’ relationship length, HIV serostatus, and
age difference between partners.
626 obs., 333 dyads, v2 (7) = 40.00, P< .001, Log likelihood =1054.15.
*P< .05; **P< .01.
SE, standard error.
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primary care provider, being in a concordantly HIV-negative
relationship, and cohabitating. Most couples also practiced
CAS within their relationship. Thirty percent of couples
had one or both partners who had sex outside of the relation-
ship. Of these relationships, 63% had one or both partners
who had CAS with a casual partner and 53% had one or
both partners who had CAS within and outside of their rela-
tionship.
Just over half of HIV-negative partnered men reported
being very to extremely likely to use PrEP (53%); the
modal response was extremely likely (30%). Men’s willing-
ness to use PrEP did not significantly differ by relationship
HIV status.
Findings from the bivariate and final multivariate random-
effects multilevel regression models are provided in Table 2.
The final random-effects multilevel regression model
revealed several factors were associated with HIV-negative
partnered men’s willingness to use PrEP. After controlling
for potential confounding factors, willingness to use PrEP
was positively associated with being in a mixed race or non-
white couple, behaviorally non-monogamous relationship,
and/or one or both partners having used amyl nitrates with
sex outside their relationship. Willingness to use PrEP was
negatively associated with being in a relationship with both
partners having at least a bachelor’s degree.
Discussion
The present investigation is one of a few studies which as-
sess willingness to use PrEP and associated factors among a
U.S. Internet sample of concordant HIV-negative and HIV-
discordant gay male couples. More than half of the HIV-
negative partnered men were very to extremely likely to
use PrEP. In contrast, in a study conducted in San Francisco
with concordant HIV-positive and HIV-discordant male
couples, Saberi and colleagues (2012) found that the major-
ity of partnered men did not endorse PrEP and some were
concerned about the possible increases in risk compensa-
tion as a result of PrEP use.53 Although this study did not
collect qualitative data to examine the reasons why part-
nered men might be more or less willing to use PrEP,
these findings provide support for partnered men’s willing-
ness to use PrEP, particularly among certain subgroups
of gay male couples. However, future research studies
that collect data from a more representative sample of
male couples would provide a greater understanding of
men’s willingness to use PrEP.
We found that men’s willingness to use PrEP increased
among those who were in a behaviorally non-monogamous
relationship. Given that most couples in this sample prac-
ticed CAS within their relationship and for some, also out-
side of their relationship, this finding is in line with the
current guidelines established by the CDC for who may
best benefit from using PrEP.20 Under certain circumstances,
HIV-negative partnered men may be at substantial risk for
HIV acquisition.2,3 Interestingly, there was no difference in
PrEP willingness between concordant negative and sero-
discordant couples, suggesting that PrEP attitudes may not
be sero dependent. Couples may perceive their risk of HIV
acquisition differently, and therefore male decision, includ-
ing their willingness to use PrEP, based on more than the
serostatus of themselves and their partner. As shown in pre-
vious clinical trial studies, PrEP can help reduce one’s risk for
acquiring HIV when it is taken consistently and as directed.14–18
Informative prevention messaging is needed to enhance
awareness and proper use of PrEP as a risk-reduction strat-
egy for partnered HIV-negative men and male couples in
non-monogamous behavioral relationships.
Men’s willingness to use PrEP increased among those who
were in a nonwhite or mixed race relationship. This finding is
significant because U.S. MSM of color are disproportion-
ately affected by HIV/AIDS compared to their white coun-
terparts.1 Educational tools and targeted messaging for this
particular population—MSM of color as well as mixed-
race male couples—is essential to help advance HIV preven-
tion via PrEP and other methods. Willingness to use PrEP
decreased among those with higher levels of education.
Although this study did not assess the reasons associated
with willingness to use PrEP (i.e., being less willing), men
in these relationships may be more skeptical about the effec-
tiveness and/or the side effects of PrEP, thereby emphasizing
the need to provide informative messaging about it to address
these possible concerns.
Limitations
The use of a cross-sectional study design with a U.S. con-
venience sample inhibits casual inference and the ability to
generalize these results to all Internet-using U.S. male cou-
ples or those who do not use Facebook. Although identifying
information was not collected, biases of participation, social
desirability, and recall may have influenced participants to
inaccurately self-report information. Further, other factors
could affect male couples’ willingness to use of PrEP, in-
cluding their mental health, presence or history of intimate
partner violence, and perceived risk for acquiring HIV. We
included responses from all couples, including couples that
did not report having outside sex partners; the responses of
such couples might have reflected their willingness to use
PrEP if their partnership became open, or if they became sin-
gle in the future. Moreover, these data were collected at a
time before PrEP was being discussed in the media and
LGBT settings and may not reflect current attitudes toward
using PrEP among partnered MSM. Future studies may ben-
efit from the inclusion of these limitations to further assess
male couples’ willingness to use PrEP and under what cir-
cumstances.
HIV-negative partnered men are willing to use PrEP, espe-
cially while in a behaviorally non-monogamous and/or
mixed race, nonwhite same-sex relationship. As strategies
are developed and added to the HIV prevention toolbox for
male couples, informative and targeted messaging is needed
to promote and enhance the uptake of these new tools, in-
cluding PrEP. We encourage additional research to better un-
derstand how dynamics within and outside of male couples’
relationships may encourage or inhibit willingness and actual
PrEP use, including their social (e.g., peers) and healthcare
environments.
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